MDXH — MDxHealth SA Income Statement
0.000.00%
- $164.33m
- $220.22m
- $90.05m
- 25
- 45
- 61
- 39
Annual income statement for MDxHealth SA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 18.5 | 22.2 | 37.1 | 70.2 | 90 |
| Cost of Revenue | |||||
| Gross Profit | 7.94 | 10.4 | 19.2 | 43.9 | 55.1 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 45.6 | 49.1 | 75 | 97.5 | 115 |
| Operating Profit | -27.1 | -26.8 | -37.9 | -27.3 | -24.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -28.7 | -29 | -44 | -43.1 | -37.7 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -28.7 | -29 | -44 | -43.1 | -38.1 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -28.7 | -29 | -44 | -43.1 | -38.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -28.7 | -29 | -44 | -43.1 | -38.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -3.41 | -2.38 | -2.77 | -1.66 | -1.16 |
| Dividends per Share |